Viruses as immunological adjuvants in cancer.
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001665:Binding Sites; D001717:Birds; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D003352:Corynebacterium / Q000276:immunology; D006801:Humans; D007109:Immunity; D015470:Leukemia, Myeloid, Acute / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology / Q000648:ultrastructure; D051379:Mice; D008807:Mice, Inbred BALB C; D008854:Microscopy, Electron; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D009975:Orthomyxoviridae / Q000276:immunology / Q000648:ultrastructure; D012441:Saccharomyces cerevisiae / Q000276:immunology*; D013045:Species Specificity; D010948:Viral Plaque Assay; D014780:Viruses / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D000956:Antigens, Viral